Elouej Sahar, Nagara Majdi, Attaoua Redha, Sallem Om Kalthoum, Rejeb Insaf, Hsouna Sana, Lasram Khaled, Halim Nizar Ben, Chargui Mariem, Jamoussi Henda, Turki Zinet, Kamoun Ines, Belfki-Benali Hanen, Abid Abdelmajid, Slama Claude Ben, Bahri Sonia, Triki Dalenda, Romdhane Habiba Ben, Abdelhak Sonia, Kefi Rym, Grigorescu Florin
Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, BP 74, 13 Place Pasteur, Tunis 1002, Consortium MEDIGENE, Tunisia; Université de Tunis El Manar, 2092 El Manar I, Tunis, Tunisia.
Molecular Endocrinology Laboratory, IURC, 641, Avenue du Doyen Gaston Giraud, 34093 Montpellier Cedex5, Consortium MEDIGENE, France.
J Diabetes Complications. 2016 Mar;30(2):206-11. doi: 10.1016/j.jdiacomp.2015.11.013. Epub 2015 Nov 14.
Variants in the fat mass and obesity-associated gene (FTO) are associated with obesity and type 2 diabetes. However, the association of FTO variants in the MENA (Middle East and North Africa) region with MetS is largely unknown. In this study, we aimed to investigate the association of FTO gene with MetS and its components in Tunisian population.
Two variants in the FTO gene were genotyped: rs1421085 T>C and rs8057044 A>G in cases and controls from Tunisian population. Anthropometric and biochemical parameters were assessed. Metabolic syndrome was defined according to the International Diabetes Federation (IDF).
The FTO rs1421085 variant conferred an increased risk to MetS (OR=1.61, 95% CI=1.14-2.26, P=0.024) that was abolished when adjusted for fasting plasma glucose (FPG), suggesting that the association may be due to variation in FPG levels. Indeed, this variant was associated to FPG (OR = 1.7, 95% CI=1.23-2.44, P=0.002) independently from BMI or age. The second polymorphism rs8057044 was associated with high blood pressure levels (OR=1.45, 95% CI=1.06-1.99, P=0.019).
This is the first study highlighting the association between FTO gene variants and MetS in Tunisian population. These findings provide evidence that FTO gene may play a critical role in leading to MetS in Tunisian population.
脂肪量和肥胖相关基因(FTO)的变异与肥胖及2型糖尿病相关。然而,中东和北非(MENA)地区FTO变异与代谢综合征(MetS)之间的关联在很大程度上尚不清楚。在本研究中,我们旨在调查突尼斯人群中FTO基因与MetS及其组分之间的关联。
对突尼斯人群的病例和对照进行FTO基因的两个变异基因分型:rs1421085 T>C和rs8057044 A>G。评估人体测量和生化参数。根据国际糖尿病联盟(IDF)定义代谢综合征。
FTO rs1421085变异增加了患MetS的风险(OR=1.61,95%CI=1.14-2.26,P=0.024),但在调整空腹血糖(FPG)后这种关联消失,这表明该关联可能归因于FPG水平的变化。实际上,该变异与FPG相关(OR = 1.7,95%CI=1.23-2.44,P=0.002),独立于体重指数(BMI)或年龄。第二个多态性rs8057044与高血压水平相关(OR=1.45,95%CI=1.06-1.99,P=0.019)。
这是第一项强调突尼斯人群中FTO基因变异与MetS之间关联的研究。这些发现提供了证据,表明FTO基因可能在突尼斯人群发生MetS中起关键作用。